Lithium Carbonate Tablet, Extended Release
Product Images NDC 62332-148

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 62332-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lithium Carbonate Er 300mg

Each tablet contains Lithium Carbonate, USP 300mg. This medication is dispensed in a tight, child-resistant container (USP) and should be stored at 20° 0 25°C (68° 0 77°F), protecting it from moisture. It is an extended-release medication and should only be taken as advised in the accompanying insert. For more information, refer to the package insert and warnings. The manufacturing unit is located in Gujarat, India, and the product is manufactured and licensed by Alembic Pharmaceuticals. The product is for prescription use only and should not be used without medical supervision or advice. The product's expiration date is December 2020.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.